Lytix Biopharma AS
OSE:LYTIX
Intrinsic Value
The intrinsic value of one LYTIX stock under the Base Case scenario is hidden NOK. Compared to the current market price of 4.83 NOK, Lytix Biopharma AS is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Lytix Biopharma AS
Fundamental Analysis

Revenue & Expenses Breakdown
Lytix Biopharma AS
Balance Sheet Decomposition
Lytix Biopharma AS
Current Assets | 53.4m |
Cash & Short-Term Investments | 43.5m |
Receivables | 9.9m |
Non-Current Assets | 2.9m |
PP&E | 2.9m |
Free Cash Flow Analysis
Lytix Biopharma AS
NOK | |
Free Cash Flow | NOK |
Earnings Waterfall
Lytix Biopharma AS
Revenue
|
10.8m
NOK
|
Operating Expenses
|
-93.5m
NOK
|
Operating Income
|
-82.8m
NOK
|
Other Expenses
|
1.9m
NOK
|
Net Income
|
-80.9m
NOK
|
LYTIX Profitability Score
Profitability Due Diligence
Lytix Biopharma AS's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Lytix Biopharma AS's profitability score is hidden . The higher the profitability score, the more profitable the company is.
LYTIX Solvency Score
Solvency Due Diligence
Lytix Biopharma AS's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Lytix Biopharma AS's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LYTIX Price Targets Summary
Lytix Biopharma AS
According to Wall Street analysts, the average 1-year price target for LYTIX is 14.28 NOK with a low forecast of 14.14 NOK and a high forecast of 14.7 NOK.
Dividends
Current shareholder yield for LYTIX is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one LYTIX stock under the Base Case scenario is hidden NOK.
Compared to the current market price of 4.83 NOK, Lytix Biopharma AS is hidden .